HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder Seeks 3%-5% Global Growth Of Estee Lauder, Clinique Brands

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder is undertaking efforts to revitalize the Estee Lauder and Clinique brands, with a goal of 3%-5% global growth of the businesses, according to the company

You may also be interested in...



Lauder’s FY 2007 Growth Strategy Presented During Analyst Meeting

Estee Lauder will increase its investment behind the Clinique brand in fiscal year 2007 in order to "facilitate growth in the U.S. and build on the brand's momentum overseas," the firm reported during a fourth quarter (ended June 30) and year-end analyst call Aug. 16

Lauder’s FY 2007 Growth Strategy Presented During Analyst Meeting

Estee Lauder will increase its investment behind the Clinique brand in fiscal year 2007 in order to "facilitate growth in the U.S. and build on the brand's momentum overseas," the firm reported during a fourth quarter (ended June 30) and year-end analyst call Aug. 16

Sean John Unforgivable Drives Fragrance Growth In Q3 – Lauder

Sean John Unforgivable fragrance more than doubled sales expectations since launch, becoming the top selling men's fragrance in U.S. department stores, according to Estee Lauder CEO William Lauder

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel